The clinical management of TRAF7 syndrome is primarily focused on addressing the individual patient's specific symptoms and needs. Given the recent description of the syndrome, the management approach is currently mostly symptomatic, tailored to each patient's clinical presentation. One of the key concerns in these patients is the management of cardiac complications, with particular attention to addressing patent ductus arteriosus, which is frequently observed. Additionally, supportive therapies such as logopedia or physiotherapy may be employed to aid in speech and motor development. Regular monitoring of developmental milestones, intellectual abilities, and behavioral aspects is essential to provide comprehensive care for individuals with TRAF7 syndrome. Ongoing research aims to unveil more effective management approaches for skeletal complications and cancer risk in TRAF7 syndrome. Future advancements in personalized care and targeted interventions hold promise for improved outcomes in these areas.
TRAF7